Crossmark

Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy

Crossref DOI link: https://doi.org/10.1186/s12974-018-1103-y

Published Online: 2018-03-01

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Navarrete, Carmen

Carrillo-Salinas, Francisco

Palomares, Belén

Mecha, Miriam

Jiménez-Jiménez, Carla

Mestre, Leyre

Feliú, Ana

Bellido, Maria L.

Fiebich, Bernd L.

Appendino, Giovanni

Calzado, Marco A.

Guaza, Carmen

Muñoz, Eduardo https://orcid.org/0000-0001-8478-5842
Funding

Funding for this research was provided by:

Secretaría de Estado de Investigación, Desarrollo e Innovación (SAF2014-53763-P, SAF2017-87701-R, SAF2016-76449-R)

Instituto de Salud Carlos III (PIE14/00005)
More Information

Article History

Received: 1 January 2018

Accepted: 21 February 2018

First Online: 1 March 2018

Ethics approval

: All experiments with laboratory animals were conducted according to European guidelines (directive 2010/63/EU) and the Ethics Committee on Animal Experimentation at the Cajal Institute (CSIC, Madrid) approved all the procedures described in this study (protocol number 96 2013/03 CEEA-IC).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.